19-13207858-CCTGCTGCTGCTGCTGCTGCTGCTGCTGCTG-CCTGCTGCTGCTGCTGCTGCTG
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP6_ModerateBS1BS2
The NM_001127222.2(CACNA1A):c.6967_6975delCAGCAGCAG(p.Gln2323_Gln2325del) variant causes a conservative inframe deletion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00275 in 1,370,548 control chromosomes in the GnomAD database, including 7 homozygotes. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.0033 ( 3 hom., cov: 0)
Exomes 𝑓: 0.0027 ( 4 hom. )
Consequence
CACNA1A
NM_001127222.2 conservative_inframe_deletion
NM_001127222.2 conservative_inframe_deletion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.785
Genes affected
CACNA1A (HGNC:1388): (calcium voltage-gated channel subunit alpha1 A) Voltage-dependent calcium channels mediate the entry of calcium ions into excitable cells, and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, and gene expression. Calcium channels are multisubunit complexes composed of alpha-1, beta, alpha-2/delta, and gamma subunits. The channel activity is directed by the pore-forming alpha-1 subunit, whereas, the others act as auxiliary subunits regulating this activity. The distinctive properties of the calcium channel types are related primarily to the expression of a variety of alpha-1 isoforms, alpha-1A, B, C, D, E, and S. This gene encodes the alpha-1A subunit, which is predominantly expressed in neuronal tissue. Mutations in this gene are associated with 2 neurologic disorders, familial hemiplegic migraine and episodic ataxia 2. This gene also exhibits polymorphic variation due to (CAG)n-repeats. Multiple transcript variants encoding different isoforms have been found for this gene. In one set of transcript variants, the (CAG)n-repeats occur in the 3' UTR, and are not associated with any disease. But in another set of variants, an insertion extends the coding region to include the (CAG)n-repeats which encode a polyglutamine tract. Expansion of the (CAG)n-repeats from the normal 4-18 to 21-33 in the coding region is associated with spinocerebellar ataxia 6. [provided by RefSeq, Jul 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
BP6
Variant 19-13207858-CCTGCTGCTG-C is Benign according to our data. Variant chr19-13207858-CCTGCTGCTG-C is described in ClinVar as [Likely_benign]. Clinvar id is 2578818.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chr19-13207858-CCTGCTGCTG-C is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00325 (481/147858) while in subpopulation AFR AF= 0.00963 (387/40188). AF 95% confidence interval is 0.00884. There are 3 homozygotes in gnomad4. There are 226 alleles in male gnomad4 subpopulation. Median coverage is 0. This position pass quality control queck.
BS2
High AC in GnomAd4 at 481 AD gene.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CACNA1A | ENST00000360228.11 | c.6967_6975delCAGCAGCAG | p.Gln2323_Gln2325del | conservative_inframe_deletion | 47/47 | 1 | NM_001127222.2 | ENSP00000353362.5 | ||
CACNA1A | ENST00000638029.1 | c.6985_6993delCAGCAGCAG | p.Gln2329_Gln2331del | conservative_inframe_deletion | 48/48 | 5 | ENSP00000489829.1 | |||
CACNA1A | ENST00000573710.7 | c.6973_6981delCAGCAGCAG | p.Gln2325_Gln2327del | conservative_inframe_deletion | 47/47 | 5 | ENSP00000460092.3 | |||
CACNA1A | ENST00000635727.1 | c.6970_6978delCAGCAGCAG | p.Gln2324_Gln2326del | conservative_inframe_deletion | 47/47 | 5 | ENSP00000490001.1 | |||
CACNA1A | ENST00000637769.1 | c.6970_6978delCAGCAGCAG | p.Gln2324_Gln2326del | conservative_inframe_deletion | 47/47 | 1 | ENSP00000489778.1 | |||
CACNA1A | ENST00000636012.1 | c.6934_6942delCAGCAGCAG | p.Gln2312_Gln2314del | conservative_inframe_deletion | 46/46 | 5 | ENSP00000490223.1 | |||
CACNA1A | ENST00000637736.1 | c.6829_6837delCAGCAGCAG | p.Gln2277_Gln2279del | conservative_inframe_deletion | 46/46 | 5 | ENSP00000489861.1 | |||
CACNA1A | ENST00000636389 | c.*53_*61delCAGCAGCAG | 3_prime_UTR_variant | 47/47 | 5 | ENSP00000489992.1 | ||||
CACNA1A | ENST00000637432 | c.*179_*187delCAGCAGCAG | 3_prime_UTR_variant | 48/48 | 5 | ENSP00000490617.1 | ||||
CACNA1A | ENST00000635895 | c.*179_*187delCAGCAGCAG | 3_prime_UTR_variant | 47/47 | 5 | ENSP00000490323.1 | ||||
CACNA1A | ENST00000638009 | c.*179_*187delCAGCAGCAG | 3_prime_UTR_variant | 47/47 | 1 | ENSP00000489913.1 | ||||
CACNA1A | ENST00000637276 | c.*179_*187delCAGCAGCAG | 3_prime_UTR_variant | 46/46 | 5 | ENSP00000489777.1 |
Frequencies
GnomAD3 genomes AF: 0.00324 AC: 478AN: 147756Hom.: 3 Cov.: 0
GnomAD3 genomes
AF:
AC:
478
AN:
147756
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00563 AC: 293AN: 52038Hom.: 1 AF XY: 0.00609 AC XY: 182AN XY: 29882
GnomAD3 exomes
AF:
AC:
293
AN:
52038
Hom.:
AF XY:
AC XY:
182
AN XY:
29882
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00269 AC: 3293AN: 1222690Hom.: 4 AF XY: 0.00289 AC XY: 1735AN XY: 601300
GnomAD4 exome
AF:
AC:
3293
AN:
1222690
Hom.:
AF XY:
AC XY:
1735
AN XY:
601300
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00325 AC: 481AN: 147858Hom.: 3 Cov.: 0 AF XY: 0.00314 AC XY: 226AN XY: 71970
GnomAD4 genome
AF:
AC:
481
AN:
147858
Hom.:
Cov.:
0
AF XY:
AC XY:
226
AN XY:
71970
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Aug 01, 2023 | CACNA1A: PM4, BS1, BS2 - |
CACNA1A-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Sep 30, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at